Clinical Commander

Back to dossier
peds.malrotation-volvulus.v1PRODUCTION
peds.malrotation-volvulus.v1

Intestinal malrotation with midgut volvulus

pediatricsacutepediatric
Hard-required inputs
0 / 20
Care setting:

Encounter flow

12/12 authored

Canonical 12-phase frame with authored status for this dossier.

Current phase

Frame

Detailed

Frame the suspected malrotation-volvulus presentation: age band (neonate < 1 mo most common 50-60 % / infant 1-12 mo / older child 1-12 y / adolescent / adult); vomiting pattern (bilious cardinal alarm vs non-bilious); duration of symptoms (> 6-8 h raises necrosis risk); hemodynamic status (stable vs dehydrated vs shock); associated syndromes (heterotaxy / CDH / omphalocele / gastroschisis / trisomy 21 / duodenal atresia coexistence).

Inputs
4
Actions
0
Advance rule
Set
Advance when

Age + vomiting pattern + duration + syndrome history tagged; pretest probability + emergency-tier framing set

Patient inputs (27)

Age band drives pretest probability + workup pathway. Neonate < 1 mo most common (50-60 % of symptomatic cases); infant 1-12 mo next; older child / adult atypical with intermittent presentation; volvulus mortality rises steeply with delayed diagnosis at any age

Mild male predominance reported; not a primary discriminator

Weight-based dosing for all fluids + electrolytes + analgesia + antibiotics; serial weights track recovery trajectory pre- and post-op

Preterm with comorbidities may present atypically; baseline frailty informs PICU / NICU level care

Tachycardia + bilious emesis raises ischemia concern; bradycardia is late ominous sign

Fever in malrotation-volvulus raises peritonitis / sepsis concern; afebrile presentation typical in early volvulus

Variable in early volvulus; pronounced distention raises closed-loop obstruction concern

Lethargic / poor-feeding infant with bilious emesis is concerning for advanced ischemia or sepsis from perforation

Heterotaxy 40-90 % prevalence; CDH / omphalocele / gastroschisis virtually universal; informs intra-operative evaluation + Ladd timing (APSA heterotaxy consensus)

Bilious is the cardinal alarm — malrotation-volvulus until proven otherwise; non-bilious raises pyloric stenosis or GER differential

Leukocytosis or leukopenia raises sepsis / ischemia concern; baseline pre-op

Lactate > 2 mmol/L raises ischemic bowel concern (LR+ ~ 5-10); metabolic acidosis from ischemia is late ominous finding; baseline pre-op + serial monitoring

Pre-surgical type-and-cross routine; transfusion need possible for extensive resection or hemodynamic instability

Pre-surgical coagulation baseline; raised in DIC from sepsis / extensive necrosis

Hypoglycemia in stressed infant; document baseline pre-op

Gold standard imaging — ligament of Treitz position + duodenal C-loop + corkscrew + beak deformity findings; sensitivity ~ 96 %, specificity ~ 98 % per SPR / ACR consensus

Hypotension by age-appropriate threshold → emergent OR (do NOT delay for imaging); IVF resuscitation in parallel; routes to id.sepsis.peds.v1 if Phoenix-2024 criteria met

Capillary refill > 3 s + mottling = shock physiology — emergent OR; resuscitation in parallel

Duration > 6-8 h correlates with higher necrosis rates; earlier presentation correlates with better salvage outcome; time-critical

Peritonitis indicates ischemic / necrotic bowel; emergent ex-lap within < 2 h; do NOT delay for imaging

Non-specific for malrotation itself; useful for free air (perforation) or paucity of distal gas; some centers obtain pre-op as baseline

Primarily for older children / adults — same SMA/SMV inversion + whirlpool + duodenal C-loop findings; avoided in neonates / infants when bedside US + UGI series available (radiation; equivalent diagnostic yield)

Modest excess risk in trisomy 21; coexistent malrotation in ~ 30 % of duodenal atresia patients — intra-op evaluation at time of duodenal repair

Prior Ladd raises recurrent-volvulus differential (~ 2-5 % recurrence); known incidentally diagnosed malrotation triggers elective Ladd consideration

Blood cultures pre-antibiotic if febrile / septic presentation suggesting peritonitis / perforation

First-line bedside screen in experienced centers; whirlpool sign sensitivity 80-90 %; SMA/SMV inversion; concurrent with UGI mobilization

Bloody stool is late finding from mucosal sloughing in ischemic bowel; raises necrosis concern

* = hard-required. Engine cannot meaningfully run until these are filled.

Severity triggers (9)

9 need judgement
  • informationallife_threateningbilious_vomiting_in_infant
    Bilious vomiting in an infant (especially < 1 month of life) — CARDINAL ALARM signal; midgut volvulus / malrotation until proven otherwise; emergent surgical evaluation + STAT upper GI series (or directly to OR if unstable); DO NOT delay surgical consult for laboratory workup or fluid resuscitation completion or imaging acquisition logistics (APSA + AAP)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningvolvulus_with_signs_of_ischemia
    Volvulus with signs of ischemia / necrotic bowel (peritonitis + lactate > 2 mmol/L + hematochezia / melena + sepsis features) — life-threatening; emergent ex-lap within < 2 h; open laparotomy preferred (exposure + viability assessment + easier resection); second-look at 24-48 h if borderline viability (APSA + pediatric GI consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningneonate_with_bilious_emesis_within_24h
    Neonate (< 24 h of life) with bilious emesis — life-threatening; differential includes malrotation-volvulus + duodenal atresia + intestinal atresia; emergent UGI + STAT surgery; cefotaxime + metronidazole substitution for ceftriaxone in < 28 d band (avoid bilirubin displacement) (APSA + AAP + Puopolo 2018)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningsuspected_malrotation_with_unstable_patient
    Suspected malrotation-volvulus in hemodynamically unstable patient — DO NOT delay for imaging; emergent ex-lap; resuscitation in parallel with OR mobilization (APSA pediatric surgical consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverefailed_ladd_or_extensive_necrosis
    Failed Ladd procedure OR extensive bowel necrosis at first operation (> 50-75 % small bowel loss; ileocecal valve loss particularly morbid) — short bowel syndrome risk; staged closure + TPN + intestinal rehabilitation; transplant evaluation in select (APSA + pediatric GI / transplant consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalsevereolder_child_atypical_malrotation
    Older child / adolescent with recurrent / intermittent crampy abdominal pain + chronic vomiting / failure to thrive — atypical malrotation; auto-detorsing intermittent volvulus; elective UGI series + surgical consult; elective laparoscopic Ladd if positive (APSA)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseveremalrotation_in_heterotaxy_or_congenital_syndromes
    Malrotation in heterotaxy syndrome / CDH / omphalocele / gastroschisis / trisomy 21 / duodenal atresia — high prevalence (40-90 % in heterotaxy; virtually universal in CDH / omphalocele / gastroschisis); intra-operative evaluation + Ladd at time of corrective procedure or staged; prophylactic Ladd in asymptomatic heterotaxy controversial (APSA heterotaxy consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalsevererecurrent_volvulus_post_op
    Recurrent volvulus post Ladd (~ 2-5 % recurrence rate) — uncommon if Ladd performed correctly; surgical re-evaluation; repeat UGI series + emergent ex-lap if confirmed (APSA pediatric surgical consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalsevereshort_bowel_syndrome_after_resection
    Short bowel syndrome after extensive resection (> 50-75 % small bowel loss; ileocecal valve loss particularly morbid) — long-term TPN + intestinal rehabilitation + transplant evaluation in select; teduglutide for adaptive failure (APSA + pediatric GI / transplant consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.

Workflow calculators

Run this disease's risk and dosing calculators inline.

TREATMENToptionalDrives dose adjustment
Loading…

Recommended regimen

Pediatric malrotation-volvulus pre-op resuscitation + perioperative antibiotics + RSI + analgesia + vasoactives (APSA + AAP + pediatric anesthesia society + Solomkin IDSA intra-abdominal 2010 peds-adapted + SSC peds 2020 + Cantey SCOUT 2016 stewardship)
axis: pediatric_malrotation_volvulus_perioperative
Selected axis "Pediatric malrotation-volvulus pre-op resuscitation + perioperative antibiotics + RSI + analgesia + vasoactives (APSA + AAP + pediatric anesthesia society + Solomkin IDSA intra-abdominal 2010 peds-adapted + SSC peds 2020 + Cantey SCOUT 2016 stewardship)" by default fallback (first axis)
  • normal saline / lactated Ringer's
    first line
    crystalloid_isotonic
    20 mL/kg IV bolus over 30-60 min, repeat × 1-2 PRN; max ~ 60 mL/kg total before reassessing for fluid overload • IV • bolus PRN with reassessment
    triggers: malrotation_with_dehydration_or_shock, pre_op_resuscitation_in_parallel_with_imaging
    AAP pediatric resuscitation principles; SSC peds 2020 if Phoenix-2024 sepsis; resuscitation in parallel with imaging / OR mobilization — do NOT delay OR for fluid completion in the unstable bilious-emesis infant
    rxcui 9863
  • D5 0.45% NaCl maintenance with electrolytes
    first line
    maintenance_fluid
    Maintenance rate with deficit replacement after first void documented • IV • continuous
    triggers: post_resuscitation_maintenance_phase
    Pre-op + post-op maintenance fluid posture
    rxcui 9863
  • cefazolin
    first line
    first_gen_cephalosporin
    25-30 mg/kg IV single dose at induction • IV • pre-op single dose
    triggers: elective_stable_ladd_pre_op_prophylaxis
    Pre-op single-dose antimicrobial prophylaxis for clean elective laparoscopic Ladd; no prolonged course (Cantey SCOUT Lancet Infect Dis 2016 PMID 27452782 stewardship principles)
    rxcui 2180
  • piperacillin-tazobactam
    first line
    penicillin_BLI
    80-100 mg/kg IV q6-8h (piperacillin component) × 5-7 d for source-controlled bowel ischemia / perforation; 7-14 d if uncontrolled source • IV • q6-8h
    triggers: confirmed_bowel_ischemia_or_perforation_or_peritonitis
    Broad Gram-positive + Gram-negative + anaerobe single-agent backbone for intra-abdominal contamination per Solomkin IDSA intra-abdominal 2010 peds-adapted PMID 20583865
    rxcui 74169
  • metronidazole
    add on
    nitroimidazole
    10 mg/kg IV q8h (max 500 mg/dose); add to cefotaxime if < 28 d (avoid ceftriaxone; AAP Puopolo 2018) • IV • q8h
    triggers: neonate_band_perforation_or_peritonitis_anaerobic_cover
    Anaerobic cover adjunct; combination alternative to single-agent pip-tazo (Solomkin IDSA 2010 peds-adapted)
    rxcui 6922
  • cefotaxime
    add on
    third_gen_cephalosporin
    50 mg/kg IV q8h (q12h if < 7 d of life and < 2 kg); preferred over ceftriaxone if < 28 d due to bilirubin-displacement risk (AAP Puopolo 2018) • IV • q8h
    triggers: neonate_band_perforation_or_peritonitis_gram_negative_cover
    Third-gen cephalosporin for neonatal-band intra-abdominal source; avoid ceftriaxone in < 28 d due to bilirubin displacement (AAP Puopolo 2018 PMID 30455342)
    rxcui 2186
  • meropenem
    rescue
    carbapenem
    20 mg/kg IV q8h × 7-14 d for severe / refractory / hospital-acquired or prior resistance • IV • q8h
    triggers: severe_or_refractory_intra_abdominal_sepsis_or_prior_resistance
    Carbapenem-grade broad-spectrum for severe or hospital-acquired or refractory intra-abdominal sepsis (Solomkin IDSA 2010 peds-adapted)
    rxcui 29561
  • vancomycin
    add on
    glycopeptide
    15 mg/kg IV q6-8h; AUC target 400-600 mg·h/L (NOT trough alone) per Rybak IDSA 2020 PMID 32191793 • IV • q6-8h
    triggers: line_source_coinfection_or_mrsa_concern
    MRSA / Gram-positive line-source cover; AUC monitoring per Rybak IDSA 2020
    rxcui 11124
  • epinephrine
    rescue
    inotrope_vasopressor
    0.05-0.3 mcg/kg/min IV (central access); titrate to age-appropriate MAP • IV • continuous
    triggers: fluid_refractory_cold_shock_post_resuscitation
    SSC peds 2020 — first-line for cold shock (pediatric phenotype)
    rxcui 3992
  • norepinephrine
    rescue
    vasopressor
    0.05-0.5 mcg/kg/min IV (central access); titrate to age-appropriate MAP • IV • continuous
    triggers: fluid_refractory_warm_shock_post_resuscitation
    SSC peds 2020 — first-line for warm shock (pediatric phenotype)
    rxcui 7512
  • acetaminophen
    first line
    analgesic_antipyretic
    10-15 mg/kg PO/PR/IV q4-6h PRN (max 60 mg/kg/day in infants; lower than older pediatric ceiling) • PO/PR/IV • q4-6h PRN
    triggers: post_op_analgesia
    First-line post-op analgesic in infants; avoid opioids when possible
    rxcui 161
  • morphine
    add on
    opioid_analgesic
    0.025-0.05 mg/kg IV PRN (HALVED infant doses vs older pediatric); 0.05-0.1 mg/kg IV PRN in older children; monitor respiratory depression with capnography • IV • PRN with monitoring
    triggers: post_op_severe_pain_unresponsive_to_acetaminophen
    For severe post-op pain; infant respiratory depression risk is elevated; HALVED doses + capnography monitoring
    rxcui 7052
  • ondansetron
    add on
    serotonin_5HT3_antagonist_antiemetic
    0.1-0.15 mg/kg IV (max 4 mg single dose); cautious in infants • IV • PRN
    triggers: post_op_persistent_emesis
    Post-op anti-emetic; FDA pediatric label considerations; minimal QT risk at single doses
    rxcui 26225

outpatient playbook — drug actions (5)

  1. 1. PO acetaminophen PRN
    10-15 mg/kg PO/PR q4-6h PRN (max 60 mg/kg/day in infants; lower than older pediatric ceiling) • PO/PR • PRN
    trigger: Post-recovery mild discomfort
    Standard infant / pediatric mild pain control
  2. 2. NO ongoing antibiotic prophylaxis
    N/A • N/A • N/A
    trigger: Uncomplicated post-recovery
    No prophylactic antibiotics post-Ladd (Cantey SCOUT 2016 stewardship)
  3. 3. TPN continuation if short bowel syndrome
    Per pediatric GI / nutrition protocol; ongoing intestinal rehabilitation • IV (central) • continuous
    trigger: Short bowel syndrome
    Long-term TPN + intestinal rehabilitation + transplant evaluation in select (APSA + pediatric GI consensus)
  4. 4. glucagon-like peptide-2 analog (teduglutide) for adaptive failure
    Per pediatric GI protocol; consider in select pediatric short bowel patients • SC • daily
    trigger: Short bowel adaptive failure
    Teduglutide reduces TPN dependence in select pediatric short bowel patients (APSA + pediatric GI consensus)
  5. 5. continue routine vaccines per ACIP
    per ACIP age-based schedule • per agent • per ACIP
    trigger: Routine well-baby / well-child care
    AAP — routine vaccination schedule maintained; post-Ladd is not a vaccination contraindication

Auto-drafted A&P note

outpatient

Subjective

- Possible entry pathways: Bilious vomiting (green / yellow-green) in an infant (especially < 1 month of life) — CARDINAL ALARM signal; malrotation with midgut volvulus until proven otherwise (APSA + AAP); emergent surgical consult + STAT upper GI series (or directly to OR if unstable); Neonate (< 24 h of life) with bilious emesis — life-threatening; differential includes malrotation-volvulus + duodenal atresia + intestinal atresia; emergent UGI + STAT surgery; Older child with recurrent / intermittent crampy abdominal pain + chronic vomiting / failure to thrive — atypical malrotation; auto-detorsing intermittent volvulus.

Objective

- No vitals, labs, or imaging entered for this encounter.

Assessment

**Intestinal malrotation with midgut volvulus** (peds.malrotation-volvulus.v1).
Phenotype framing: Bilious emesis differential in infant: malrotation-volvulus (cardinal; emergent UGI + surgery) / duodenal atresia (bilious emesis in first 24-48 h of life; double-bubble + no distal gas on KUB; coexistent malrotation in ~ 30 %) / intestinal atresia (bilious emesis + distal-bowel obstruction pattern) / NEC (preterm neonate; pneumatosis intestinalis on KUB — `peds.nec.v1`) / sepsis with ileus (febrile, lethargic; routes to id.neonatal-sepsis.early-late.v1 or id.sepsis.peds.v1) / incarcerated inguinal hernia (palpable groin mass + irreducible) / intussusception (different age band 6 mo - 3 y typically non-bilious initially; `peds.intussusception.v1`). Non-bilious differential: pyloric stenosis (non-bilious projectile in 2-8 wk infant; `peds.pyloric-stenosis.v1`) / GER / formula intolerance. Older-child differential: chronic abdominal pain ddx (functional, IBS-like, intermittent malrotation, abdominal migraine, gastroparesis).
Scope: Frame the suspected malrotation-volvulus presentation: age band (neonate < 1 mo most common 50-60 % / infant 1-12 mo / older child 1-12 y / adolescent / adult); vomiting pattern (bilious cardinal alarm vs non-bilious); duration of symptoms (> 6-8 h raises necrosis risk); hemodynamic status (stable vs dehydrated vs shock); associated syndromes (heterotaxy / CDH / omphalocele / gastroschisis / trisomy 21 / duodenal atresia coexistence).

No severity triggers fired against current inputs.

Plan

Regimen axis: **Pediatric malrotation-volvulus pre-op resuscitation + perioperative antibiotics + RSI + analgesia + vasoactives (APSA + AAP + pediatric anesthesia society + Solomkin IDSA intra-abdominal 2010 peds-adapted + SSC peds 2020 + Cantey SCOUT 2016 stewardship)**.
1. normal saline / lactated Ringer's 20 mL/kg IV bolus over 30-60 min, repeat × 1-2 PRN; max ~ 60 mL/kg total before reassessing for fluid overload IV bolus PRN with reassessment (crystalloid_isotonic, first line) — AAP pediatric resuscitation principles; SSC peds 2020 if Phoenix-2024 sepsis; resuscitation in parallel with imaging / OR mobilization — do NOT delay OR for fluid completion in the unstable bilious-emesis infant
2. D5 0.45% NaCl maintenance with electrolytes Maintenance rate with deficit replacement after first void documented IV continuous (maintenance_fluid, first line) — Pre-op + post-op maintenance fluid posture
3. cefazolin 25-30 mg/kg IV single dose at induction IV pre-op single dose (first_gen_cephalosporin, first line) — Pre-op single-dose antimicrobial prophylaxis for clean elective laparoscopic Ladd; no prolonged course (Cantey SCOUT Lancet Infect Dis 2016 PMID 27452782 stewardship principles)
4. piperacillin-tazobactam 80-100 mg/kg IV q6-8h (piperacillin component) × 5-7 d for source-controlled bowel ischemia / perforation; 7-14 d if uncontrolled source IV q6-8h (penicillin_BLI, first line) — Broad Gram-positive + Gram-negative + anaerobe single-agent backbone for intra-abdominal contamination per Solomkin IDSA intra-abdominal 2010 peds-adapted PMID 20583865
5. metronidazole 10 mg/kg IV q8h (max 500 mg/dose); add to cefotaxime if < 28 d (avoid ceftriaxone; AAP Puopolo 2018) IV q8h (nitroimidazole, add on) — Anaerobic cover adjunct; combination alternative to single-agent pip-tazo (Solomkin IDSA 2010 peds-adapted)
6. cefotaxime 50 mg/kg IV q8h (q12h if < 7 d of life and < 2 kg); preferred over ceftriaxone if < 28 d due to bilirubin-displacement risk (AAP Puopolo 2018) IV q8h (third_gen_cephalosporin, add on) — Third-gen cephalosporin for neonatal-band intra-abdominal source; avoid ceftriaxone in < 28 d due to bilirubin displacement (AAP Puopolo 2018 PMID 30455342)
7. meropenem 20 mg/kg IV q8h × 7-14 d for severe / refractory / hospital-acquired or prior resistance IV q8h (carbapenem, rescue) — Carbapenem-grade broad-spectrum for severe or hospital-acquired or refractory intra-abdominal sepsis (Solomkin IDSA 2010 peds-adapted)
8. vancomycin 15 mg/kg IV q6-8h; AUC target 400-600 mg·h/L (NOT trough alone) per Rybak IDSA 2020 PMID 32191793 IV q6-8h (glycopeptide, add on) — MRSA / Gram-positive line-source cover; AUC monitoring per Rybak IDSA 2020
9. epinephrine 0.05-0.3 mcg/kg/min IV (central access); titrate to age-appropriate MAP IV continuous (inotrope_vasopressor, rescue) — SSC peds 2020 — first-line for cold shock (pediatric phenotype)
10. norepinephrine 0.05-0.5 mcg/kg/min IV (central access); titrate to age-appropriate MAP IV continuous (vasopressor, rescue) — SSC peds 2020 — first-line for warm shock (pediatric phenotype)
11. acetaminophen 10-15 mg/kg PO/PR/IV q4-6h PRN (max 60 mg/kg/day in infants; lower than older pediatric ceiling) PO/PR/IV q4-6h PRN (analgesic_antipyretic, first line) — First-line post-op analgesic in infants; avoid opioids when possible
12. morphine 0.025-0.05 mg/kg IV PRN (HALVED infant doses vs older pediatric); 0.05-0.1 mg/kg IV PRN in older children; monitor respiratory depression with capnography IV PRN with monitoring (opioid_analgesic, add on) — For severe post-op pain; infant respiratory depression risk is elevated; HALVED doses + capnography monitoring
13. ondansetron 0.1-0.15 mg/kg IV (max 4 mg single dose); cautious in infants IV PRN (serotonin_5HT3_antagonist_antiemetic, add on) — Post-op anti-emetic; FDA pediatric label considerations; minimal QT risk at single doses

Setting playbook (outpatient) — Post-discharge pediatrician + pediatric surgery + pediatric GI follow-up; recurrence surveillance (~ 2-5 % post-Ladd); short bowel rehabilitation if extensive resection; intestinal transplant program for irreversible TPN dependence
14. PO acetaminophen PRN 10-15 mg/kg PO/PR q4-6h PRN (max 60 mg/kg/day in infants; lower than older pediatric ceiling) PO/PR PRN — Post-recovery mild discomfort (Standard infant / pediatric mild pain control)
15. NO ongoing antibiotic prophylaxis N/A N/A N/A — Uncomplicated post-recovery (No prophylactic antibiotics post-Ladd (Cantey SCOUT 2016 stewardship))
16. TPN continuation if short bowel syndrome Per pediatric GI / nutrition protocol; ongoing intestinal rehabilitation IV (central) continuous — Short bowel syndrome (Long-term TPN + intestinal rehabilitation + transplant evaluation in select (APSA + pediatric GI consensus))
17. glucagon-like peptide-2 analog (teduglutide) for adaptive failure Per pediatric GI protocol; consider in select pediatric short bowel patients SC daily — Short bowel adaptive failure (Teduglutide reduces TPN dependence in select pediatric short bowel patients (APSA + pediatric GI consensus))
18. continue routine vaccines per ACIP per ACIP age-based schedule per agent per ACIP — Routine well-baby / well-child care (AAP — routine vaccination schedule maintained; post-Ladd is not a vaccination contraindication)

Non-pharmacologic actions:
- Family education reinforcement on return precautions (recurrent bilious emesis → ED for repeat UGI; ~ 2-5 % recurrence post-Ladd)
- Lactation continuation support if breastfeeding
- Weight-gain trajectory tracking at every visit
- Routine well-baby / well-child care + ongoing vaccination per ACIP
- Pediatric GI consult queued for short bowel rehabilitation if applicable
- Intestinal transplant program referral for irreversible TPN dependence
- Heterotaxy / CDH / omphalocele / gastroschisis patients — coordinate ongoing multidisciplinary follow-up for index syndrome
- Family caregiver psychosocial check at follow-up (surgical infant illness can be traumatic for first-time parents)

AVOID / contraindication checks:
- Bilious vomiting in infant = malrotation volvulus until proven otherwise; emergent surgical consult + STAT upper GI series (APSA + AAP)
- Open laparotomy preferred for acute volvulus + suspected ischemia (APSA pediatric surgical consensus)
- Laparoscopic appropriate for stable elective Ladd only (APSA)
- Second look operation at 24 48 h for borderline bowel viability — preserve maximum bowel length to avoid short bowel syndrome (APSA + pediatric GI consensus)
- Rapid sequence induction in bilious emesis infant — full stomach + aspiration risk (pediatric anesthesia society)
- NG decompression pre op to reduce aspiration risk (pediatric anesthesia society)
- Avoid nitrous oxide in suspected bowel obstruction — diffuses into bowel + worsens distention (pediatric anesthesia society)
- Pre op single dose cefazolin only for elective stable Ladd in clean contaminated cases (Cantey SCOUT Lancet Infect Dis 2016 PMID 27452782)
- Broad spectrum pip tazo or meropenem for confirmed bowel ischemia / perforation × 5 7 d source controlled; 7 14 d uncontrolled source (Solomkin IDSA 2010 peds adapted PMID 20583865)
- Ceftriaxone avoid under 28 days bilirubin displacement (FDA 2009; AAP Puopolo 2018 PMID 30455342) — substitute cefotaxime in neonatal band case
- Fluid bolus 20 mL per kg with reassessment pediatric AAP DDC (AAP pediatric resuscitation principles); resuscitation in parallel with imaging / OR — do NOT delay OR for fluid completion in unstable patient
- Morphine respiratory depression in infants — HALVED doses + capnography monitoring
- Gentamicin extended interval by gestational age neonate (AAP Puopolo 2018; Neofax) — applies if neonatal band case requires aminoglycoside
- Vancomycin AUC target not trough (Rybak IDSA 2020 PMID 32191793) — applies if line source coinfection
- Source control within 6 12 h for confirmed bowel ischemia / perforation (Solomkin IDSA 2010; SSC peds 2020)

Monitoring

Regimen monitoring:
- continuous vitals during pre-op + intra-op + post-op
- capnography during intra-op anesthesia + post-extubation in very young or comorbid (pediatric anesthesia society)
- serial lactate + CBC + CMP q6-8h × first 24-48 h then q12-24h until discharge
- serial abdominal exams q4h post-op for wound + bowel sounds + distention pattern
- NG output volume + character
- feed advance progression from clear liquids → formula / breast milk as tolerated post-bowel-function return (typically 3-7 d post-Ladd; longer for resection)
- serial weights daily
- second-look operation at 24-48 h if borderline bowel viability
- antibiotic course tracking (5-7 d source-controlled; 7-14 d uncontrolled)
- short bowel monitoring if extensive resection: stool / ostomy output volume, electrolyte balance, growth trajectory, TPN tolerance, line-source infection surveillance
- family-bedside-instruction documentation on return precautions for recurrent symptoms + recurrence rate ~ 2-5 % post-Ladd

Setting (outpatient) monitoring:
- Pediatrician visit at 1-2 weeks, 4-6 weeks, then routine well-baby / well-child care
- Pediatric surgery at 2-4 weeks post-op
- Pediatric GI at 4-6 weeks for short bowel management if applicable
- Intestinal transplant program if irreversible TPN dependence
- Vaccination catch-up review at every well-baby / well-child visit

Follow-up plan: Post-op pediatric surgical follow-up at 2-4 weeks for wound check + scar inspection + weight-gain review; pediatrician follow-up within 1-2 weeks for routine well-baby / well-child care including weight-gain trajectory + feeding tolerance; pediatric GI consult at 4-6 weeks for short bowel syndrome management if applicable (TPN tolerance, enteral advance, line-source surveillance, glucagon-like peptide-2 analog teduglutide consideration in select); intestinal transplant program referral for irreversible TPN dependence + life-threatening complications (APSA + pediatric GI / transplant consensus); recurrence surveillance for the ~ 2-5 % post-Ladd recurrence rate (return precautions taught + low threshold for repeat UGI on recurrent symptoms). Heterotaxy / CDH / omphalocele / gastroschisis patients — ongoing multidisciplinary follow-up for index syndrome.
- Close-out criterion: Follow-up scheduled + return precautions delivered + family education complete + short bowel program enrolled if applicable + recurrence surveillance plan in place

Monitoring phase: Post-op vitals q1-2h × first 6 h then q4h; serial abdominal exams q4h; serial lactate + CBC + CMP q6-8h × first 24-48 h then q12-24h; wound inspection daily; NG output + character; feed advance from clear liquids → formula / breast milk as tolerated post-bowel-function return (typically 3-7 d post-Ladd; longer for resection); strict I/O; serial weights daily; capnography post-extubation in very young or comorbid (pediatric anesthesia society). Second-look operation at 24-48 h if borderline viability — preserve maximum bowel length. Antibiotic course tracking (5-7 d for source-controlled; 7-14 d if uncontrolled source). Short bowel monitoring: stool / ostomy output volume, electrolyte balance, growth trajectory, TPN tolerance, line-source infection surveillance.

Disposition

Current setting: outpatient — Post-discharge pediatrician + pediatric surgery + pediatric GI follow-up; recurrence surveillance (~ 2-5 % post-Ladd); short bowel rehabilitation if extensive resection; intestinal transplant program for irreversible TPN dependence

Disposition criteria:
- Sustained recovery — normal feeds + bowel function + weight-gain trajectory at age-appropriate baseline + no recurrent episodes in 4-6 wk + family demonstrating return-precaution knowledge

Escalation triggers (move to higher acuity):
- Recurrent bilious emesis post-discharge → return to ED for repeat UGI + management (~ 2-5 % recurrence post-Ladd)
- Wound issues (drainage, fever, erythema) → urgent pediatric surgery + ED reassessment
- Failure to gain weight after expected post-op recovery → pediatric GI + surgery reassessment
- Short bowel adaptation failure with irreversible TPN dependence → intestinal transplant program referral
- Family caregiver acute distress / PTSD symptoms after traumatic illness → mental-health referral

Earlier-Return Triggers

Return-precaution thresholds (watch for):
- [LIFE_THREATENING] Bilious vomiting in an infant (especially < 1 month of life) — CARDINAL ALARM signal; midgut volvulus / malrotation until proven otherwise; emergent surgical evaluation + STAT upper GI series (or directly to OR if unstable); DO NOT delay surgical consult for laboratory workup or fluid resuscitation completion or imaging acquisition logistics (APSA + AAP)
- [LIFE_THREATENING] Volvulus with signs of ischemia / necrotic bowel (peritonitis + lactate > 2 mmol/L + hematochezia / melena + sepsis features) — life-threatening; emergent ex-lap within < 2 h; open laparotomy preferred (exposure + viability assessment + easier resection); second-look at 24-48 h if borderline viability (APSA + pediatric GI consensus)
- [LIFE_THREATENING] Neonate (< 24 h of life) with bilious emesis — life-threatening; differential includes malrotation-volvulus + duodenal atresia + intestinal atresia; emergent UGI + STAT surgery; cefotaxime + metronidazole substitution for ceftriaxone in < 28 d band (avoid bilirubin displacement) (APSA + AAP + Puopolo 2018)

Citations

- APSA (American Pediatric Surgical Association) pediatric surgical-emergency guidance for malrotation + midgut volvulus + AAP infant-vomiting guidance + ACR Appropriateness Criteria — Vomiting in Infants Up to 3 Months of Age + SPR / ACR consensus on UGI series technique (ligament of Treitz position + duodenal C-loop + corkscrew + beak deformity findings; sensitivity ~ 96 %, specificity ~ 98 %) + APSA heterotaxy / CDH / omphalocele / gastroschisis consensus (high malrotation prevalence; prophylactic Ladd controversial) + APSA short bowel syndrome consensus + pediatric GI / transplant programs (long-term TPN + intestinal rehabilitation; teduglutide for adaptive failure; intestinal transplant for irreversible TPN dependence) + Pediatric anesthesia society consensus (RSI for full stomach + aspiration risk; NG decompression pre-op; avoid nitrous oxide in suspected obstruction) + Solomkin IDSA Complicated Intra-Abdominal Infection 2010 PMID 20583865 (peds-adapted for confirmed bowel ischemia + perforation / peritonitis) + SSC peds 2020 (for shock physiology if bowel necrosis precipitates sepsis) [PMID:20583865](https://pubmed.ncbi.nlm.nih.gov/20583865/)
- Cited evidence (PMID 32191793) [PMID:32191793](https://pubmed.ncbi.nlm.nih.gov/32191793/)
- Cited evidence (PMID 27452782) [PMID:27452782](https://pubmed.ncbi.nlm.nih.gov/27452782/)
- Cited evidence (PMID 30455342) [PMID:30455342](https://pubmed.ncbi.nlm.nih.gov/30455342/)

Last reconciled with current guidelines: 2026-05-15.
References
  • APSA (American Pediatric Surgical Association) pediatric surgical-emergency guidance for malrotation + midgut volvulus + AAP infant-vomiting guidance + ACR Appropriateness Criteria — Vomiting in Infants Up to 3 Months of Age + SPR / ACR consensus on UGI series technique (ligament of Treitz position + duodenal C-loop + corkscrew + beak deformity findings; sensitivity ~ 96 %, specificity ~ 98 %) + APSA heterotaxy / CDH / omphalocele / gastroschisis consensus (high malrotation prevalence; prophylactic Ladd controversial) + APSA short bowel syndrome consensus + pediatric GI / transplant programs (long-term TPN + intestinal rehabilitation; teduglutide for adaptive failure; intestinal transplant for irreversible TPN dependence) + Pediatric anesthesia society consensus (RSI for full stomach + aspiration risk; NG decompression pre-op; avoid nitrous oxide in suspected obstruction) + Solomkin IDSA Complicated Intra-Abdominal Infection 2010 PMID 20583865 (peds-adapted for confirmed bowel ischemia + perforation / peritonitis) + SSC peds 2020 (for shock physiology if bowel necrosis precipitates sepsis) — PMID:20583865
  • Cited evidence (PMID 32191793) — PMID:32191793
  • Cited evidence (PMID 27452782) — PMID:27452782
  • Cited evidence (PMID 30455342) — PMID:30455342